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We have previously shown that the replication of avian reovirus (ARV) in chicken 
embryo fibroblasts (CEF) is more resistant to the antiviral action of interferon (IFN) 
than the replication of vesicular stomatitis virus (VSV) or vaccinia virus (VV). In this 
study we examined the capacity of these three viruses to induce the expression of IFN 
when infecting avian cells. Efficient expression of both type- and type- IFNs, as well 
as of the double-stranded RNA (dsRNA)-activated protein kinase (PKR), takes place in 
ARV-infected CEF, but not in cells infected with VSV or VV. PKR expression is not 
directly induced by ARV infection, but by the IFN secreted by ARV-infected cells. IFN 
induction in ARV-infected cells requires viral uncoating, but not viral gene expression, 
a situation similar to that reported for apoptosis induction by ARV-infected cells. 
However, our results demonstrate that IFN induction by ARV-infected CEF occurs by a 











































































 Interferons (IFNs) comprise a family of multifunctional cytokines that were 
originally discovered by their strong antiviral activity (Isaacs and Lindenmann, 1957), 
and which are now recognized as the first barrier that viruses have to overcome to 
establish a productive infection. Of the three IFN types, type I interferon- displays 
the highest antiviral activity and its expression is induced in many cell types by viral 
infection or following contact with double-stranded RNA (dsRNA) (reviewed in 
Samuel, 2001).  
Successful host defense against viruses relies on early detection of intracellular 
virus particles followed by the rapid production of type I interferons. For this, cells 
contain a series of endosomal and cytosolic sensors, called pattern recognition receptors 
(PRRs), which recognize pathogen associated molecular patterns (PAMPs), such as 
viral nucleic acids or viral intermediate products. When contacting PAMPs, PRRs 
become activated and transmit intracellular signaling pathways, culminating in the 
activation of specific transcription factors that translocate to the nucleus to stimulate 
type I IFN promoters (reviewed in Diebold, 2010; Edwards et al., 2007; Jefferies and 
Fitzgerald, 2005; Koyama et al., 2008; Yoneyama and Fujita, 2010). Newly-synthesized 
type I IFNs are secreted out of the cell to interact with the ubiquitously expressed 
IFNAR receptor complex present in neighboring cells. This interaction triggers the 
activation of a signal transduction pathway that leads to increased expression of the 
designated IFN-stimulated genes (ISGs), thus creating an antiviral state. Subsequent 
viral infection of IFN-primed cells induces the activation of ISG-encoded proteins; the 
antiviral activity of these proteins prevents further dissemination of the virus (reviewed 
in Doly et al., 1998; Haller et al., 2006; Sadler and Williams, 2008; Samuel, 2001; 




































































 Despite that IFN was initially discovered as a soluble chicken factor that directly 
interfered with influenza virus replication in chorioallontoic membranes of chicken 
embryos (Isaacs and Lindenmann, 1957), our understanding of the host response to 
pathogens in poultry is very limited, since most efforts were dedicated at characterizing 
the antiviral response in mammals. However, interest in IFNs of birds has recently 
emerged from increasing problems with viral diseases in poultry and from the 
observation that chickens infected with highly pathogenic avian influenza virus strains 
pose a high threat to human health (Fouchier et al., 2013; Karpala et al., 2012; 
Poovorawan et al., 2013). As in mammals, three types of chicken IFN (chIFN) have 
been identified in virus-infected chicken cells, and all three have been reported to 
display antiviral activity (reviewed in Goosens et al., 2013). Type I chIFN, which 
comprises multiple chIFN- isoforms and a single chIFN-, has the strongest antiviral 
activity, although chIFN- is the dominant virus-induced IFN subtype produced by 
virus-infected avian cells (Schultz et al., 1995; Schwarz et al., 2004), a situation 
opposite to the one found in mammalian-infected cells. This, and the observations that 
chIFN- exhibits stronger antiviral activity than chIFN- against several viruses and 
greater induction potency on several ISGs encoding antiviral proteins (Qu et al., 2013; 
Schwarz et al., 2004), suggests that chIFN-is the main defense used by chicken cells 
to combat viral infections. 
Previous studies from different laboratories, including ours, have revealed that 
the replication of avian reovirus (ARV) in cultured avian cells is much more resistant to 
the antiviral action of chIFN than vaccinia virus (VV), vesicular stomatitis virus (VSV) 
or Semliki Forest virus (Ellis et al., 1983; Gonzalez-Lopez et al., 2003; Martinez-Costas 
et al., 2000; Sekellick et al., 1994). In this study we have examined the capacity of 




































































IFN is only expressed and secreted by ARV-infected cells and that IFN induction 








































































IFN induction by virus-infected avian cells  
 In the first part of this study we sought to compare the capacity of ARV, VV and 
VSV to induce the production and secretion of IFN by infected avian cells. Our 
previous finding that VSV and VV are very sensitive to priming of CEF cells with IFN 
(Martinez-Costas et al., 2000) suggests that IFN should not be secreted by avian cells 
infected with these two viruses, otherwise the IFN present in the viral stocks used to 
infect the cells would block viral replication. In the case of VV, this suggestion is 
supported by the results of previous studies that revealed that chIFN activity was not 
detected upon infection of CEF cells with wild-type VV (Hornemann et al., 2003). In 
contrast, it has been recently reported that infection of the CEF-derived avian cell line 
DF1 with VSV induces increasing expression of the mRNAs coding for chIFN- and 
chIFN- (Qu et al., 2013), although the presence of IFN in the cultured medium of 
VSV-infected cells was not examined in this study.  
To determine the capacity of the three viruses to induce chIFN expression, we 
first analyzed by Western blot the intracellular levels of the IFN-inducible protein PKR 
in virus-infected CEF cells. Since the possibility existed that IFN is produced and 
secreted by ARV-infected CEF, and consequently that the ARV stock used to infect the 
cells contains chIFN, the infection with ARV was carried out with a suspension of 
purified reovirions devoid of cellular proteins (Grande and Benavente, 2000). VSV and 
VV viruses did not require purification since these viruses were grown on BHK-21 
hamster cells and therefore their stocks should not contain chIFN. The results shown in 
Fig. 1A revealed that PKR expression was induced when the cells were infected with 




































































ARV-infected cells. To confirm this suggestion, we analyzed the presence of IFN in the 
cultured medium (supernatant) of virus-infected CEF cells by two different approaches. 
In the first approach, we examined the capacity of virus-free supernatants to induce 
PKR expression when incubated with monolayers of uninfected CEF. Viral particles 
were removed from the supernatants of infected cells by precipitation with perchloric 
acid at 4ºC, as previously reported (Sekellick and Marcus, 1986), but similar results 
were obtained when the viral particles were inactivated by incubating the supernatants 
at 65ºC for 30 min (Liniger et al., 2012). The results shown in Fig. 1B revealed that 
only the supernatant from ARV-infected cells, but not those from cells infected with 
VSV or VV, was able to induce the expression of PKR. In the second approach, we 
determined the capacity of the supernatants to activate the promoter of the chicken Mx 
gene contained within the reporter pGL3-P-chMx-luc plasmid (Liniger et al., 2012). 
The supernatants were incubated with plasmid-transfected DF1 cells, since control 
experiments revealed that the transfection of any plasmid into CEF cells, but not into 
DF1 cells, already induces PKR expression (not shown). The results shown in Fig. 1C 
revealed that only the supernatant from ARV-infected CEF was able to activate the Mx 
promoter. Taken together, these results demonstrate that infection of CEF with ARV, 
but not with VSV or VV, induces the production and secretion of chIFN. Our results 
further revealed that the secreted IFN is functional in both CEF and DF1 cells, since it is 
able to activate the expression of those IFN-responsive genes expressing PKR and Mx. 
 
ARV-infected CEF secrete type-andtype-IFNs
 To try to determine the type of chIFN (or ) produced by ARV-infected CEF 
cells, antibodies to chIFN- and/or - were added to the culture medium of the infected 




































































results revealed that each of the two antibodies was capable of inhibiting PKR 
induction, although maximal inhibition was only reached when the two antibodies were 
simultaneously present in the culture medium (Fig. 2A). These results not only indicate 
that ARV-infected CEF cells secrete type- and type- chIFNs, but also suggest that 
PKR is indirectly induced in these cells by the IFN secreted to the cultured medium. To 
confirm this suggestion we analyzed the effect of brefeldin A (BFA) on PKR 
expression. BFA is a macrolide antibiotic that has been shown to inhibit vesicle 
transport to the cell surface, by causing the resorption of the Golgi complex into the 
endoplasmic reticulum (Miller et al., 1992; Nebenführ et al., 2002). It has been shown 
that 0.25 g/ml of BFA only caused a slight reduction of both intracellular muNS levels 
and the production of infectious viral particles (Bodelon et al., 2002), indicating that 
this antibiotic hardly affects ARV replication and assembly. On the other hand, trypan 
blue staining of BFA-treated CEF cells revealed that ~95% of the cells were viable after 
an incubation period of 18 h. The results shown in Fig. 2B revealed that PKR 
expression is no longer induced when ARV-infected CEF cells are incubated in the 
presence of 0.5 g/ml of BFA (upper panel, compare lanes 4 and 6), suggesting that 
PKR is not directly induced by the viral infection, but by the IFN secreted by ARV-
infected CEF cells.   
 
IFN induction in ARV-infected cells requires viral uncoating, but not viral gene 
expression 
 Our next goal was to try to identify the stage of the ARV life cycle at which IFN 
expression is induced. First of all, we determined the relative production of chIFN- 
mRNA in ARV-infected CEF at different infection times. We analyzed the intrcellular 




































































chIFN- genes. Real-time PCR analysis revealed that increased expression of the 
chIFN- mRNA was already observed at 3 hpi and its intracellular levels increased 
significantly at 6 hpi (Fig. 3A), indicating that strong induction of the chIFN- gene 
takes place at early infection times. To confirm this result we analyzed the intracellular 
PKR levels and the capacity of the supernatants to activate the Mx promoter at different 
infection times. Induction of PKR expression was already detected at 6 hpi and 
intracellular PKR levels increased with time until 12 hpi, and then declined probably 
because of the damage caused by the infection, as revealed by diminished actin levels 
(Fig. 3B). On the other hand, the capacity of the supernatant from infected cells to 
activate the Mx promoter was already detected at 3 hpi and steadily increased until 12 
hpi (Fig. 3C). These results indicate that IFN expression is induced at an early stage of 
the ARV replication cycle. To try to identify that stage we first assessed whether 
intracellular virus uncoating is required for IFN induction. For this, we examined the 
effect of two lysosomotropic agents, ammonium chloride and chloroquine, that have 
been previously shown to prevent intraendosomal ARV uncoating by neutralizing 
vacuolar acidification; as a consequence virus protein synthesis and virus replication is 
blocked in ARV-infected CEF incubated in the presence of any of these two agents  
(Labrada et al., 2002). The results shown in Fig. 4A revealed that each of the two 
inhibitors was very effective in preventing PKR induction when added to cells at the 
onset of the infection (lanes 3 and 5), but not when added 3 h later (lanes 4 and 6). 
Furthermore, the supernatants from ARV-infected CEF that had been incubated with 
either of the two inhibitors from the onset of the infection, but not when added 3 h later, 
were no longer able to activate the Mx promoter (Fig. 4B). These results indicate that 




































































 To determine whether ARV gene expression is necessary for IFN induction, we 
first evaluated the effect of ribavirin, a nucleoside analog that has been reported to block 
ARV transcription without affecting the expression of cellular genes (Labrada et al., 
2002). Our finding that the production of the ARV nonstructural muNS protein is 
blocked when ARV-infected cells are incubated in the presence of 100  ribavirin 
indicates that the nucleoside analog is effective in blocking ARV gene expression 
(compare lanes 3 and 4 in the middle panel of Fig. 5A). However, ribavirin failed to 
inhibit PKR expression in ARV-infected CEF (compare lanes 3 and 4 in the upper panel 
of Fig. 5A), and the supernatant from ribavirin-treated ARV-infected cells was still able 
to activate the Mx promoter (Fig. 5B). Since ribavirin has been shown to induce the 
expression of a subset of the IFN-responsive genes in uninfected cells (Thomas et al., 
2011), we followed an alternative approach to examine whether ARV gene expression 
is required for IFN induction. For this, we evaluated the capacity of ultraviolet-
inactivated ARV virions to induce IFN expression. As previously shown (Labrada et al., 
2002), treatment of purified reovirions with ultraviolet light (UV) completely blocked 
ARV gene expression, as revealed by the absence of muNS production (compare lanes 2 
and 3 in the middle panel of Fig. 5C), and also caused inactivation of virus infectivity as 
determined by plaque assay (not shown). In contrast, PKR expression was still induced 
when CEF cells were incubated with UV-treated virions (lane 3 in the upper panel of 
Fig. 5C), and the supernatant from these cells was still able to activate the Mx promoter 
(Fig. 5D). Taken together, these results indicate that viral gene expression is not 
required for IFN induction in ARV-infected CEF. 
 





































































The results shown so far indicate that IFN is induced in ARV-infected CEF at a 
stage of the virus life cycle subsequent to virus uncoating, but prior to virus gene 
expression. Since a similar situation has been previously reported for apoptosis 
induction in ARV-infected cells (Labrada et al., 2002), we next examined whether 
apoptosis is required for IFN induction in ARV-infected cells. For this, we examined 
the effect of the pancaspase inhibitor Q-VD-OPh, which has been shown to be very 
effective in preventing the activation of effector caspases and the conversion of muNS 
into muNSC in ARV-infected CEF (Rodriguez-Grille et al., 2014). The results revealed 
that, while the caspase inhibitor was very effective in preventing both the activation of 
effector caspases (Fig. 6A) and the conversion of muNS into muNSC (middle panel of 
Fig. 5B, compare lanes 3 and 4), Q-VD-OPh was unable to inhibit PKR expression by 
ARV-infected cells (upper panel of Fig. 6B, compare lanes 3 and 4). These results 







































































 In this study we have analyzed the capacity of three different viruses to induce 
the expression of IFN when infecting CEF cells. The results revealed that only the 
infection with ARV, but not with VSV or VV, induces the expression and secretion of 
chIFN, which in turn indicates that signaling pathways mediating IFN gene expression 
are nonfunctional in VSV- or VV-infected avian cells. In the case of VV, it has been 
reported that the genome of this virus expresses a broad range of immune modulators, 
and some of them have been shown to block IFN expression by inhibiting PRR 
signaling pathways (Perdiguero and Esteban, 2009; Smith et al., 2013; Waibler et al., 
2009). Our finding that IFN is not expressed by VV-infected CEF cells suggests that 
some of these viral modulators are active in avian cells. On the other hand, the absence 
of IFN induction that we have observed in VSV-infected CEF might be attributed to the 
capacity of the viral M protein to prevent IFN expression. This protein has been 
reported to block IFN induction in infected mammal cells by inhibiting nuclear 
transcription and the nucleocytoplasmic transport of cellular mRNAs (Ahmed et al., 
2003; Faul et al., 2009; Ferran and Lucas-Lenard, 1997). Our unpublished observation 
that cellular mRNAs accumulate within the nucleus of CEF cells, together with the fact 
that cellular protein synthesis is drastically reduced in VSV-infected CEF (Martinez-
Costas et al., 2000), suggest that the M protein also plays a key role in preventing IFN 
induction in VSV-infected avian cells. Other viruses, like influenza viruses A and B, 
Thogoto virus, herpes simplex virus type 1, human immunodeficiency virus, and 
Epstein-Barr virus, have also been reported to use mechanisms for blocking IFN 





































































 The results of this study revealed that type- and type- IFNs are both produced 
by ARV-infected CEF cells, a situation similar to that reported for CEF cells infected 
with MVA or with an NS1-defective influenza virus. In contrast, only IFN- was 
detected during the infection of CEF with Newcastle disease virus, Rift valley fever 
virus, or Thogoto virus (Schwarz et al., 2004). Additional experiments were performed 
to assess the stage of the ARV life cycle at which the expression of IFN is induced. Our 
findings revealed that IFN expression is induced at an early stage of the virus 
replication cycle. This suggestion is supported by the fact that IFN induction does not 
require expression of the ARV genes, since it takes place when the cells are incubated 
with UV-treated virus or when ARV-infected cells are incubated in the presence of 
ribavirin. In both cases IFN expression, but not the expression of ARV genes, was 
detected. The nondependence of IFN induction on viral gene expression indicates that 
IFN is induced by parental viral particles at a stage prior to viral transcription and 
suggests that viral mRNAs and viral nonstructural proteins should not act as IFN 
inducers. However, the possibility still exists that abortive transcripts produced in cells 
incubated with UV-treated reovirions or in ribavirin-treated ARV-infected cells could 
act as IFN inducers. Thus, it has been reported that UV-treatment of mammalian 
reovirions generates particles that are able to synthesize small amounts of incomplete 
viral transcripts (Henderson and Joklik, 1978) and, if the same holds true for the 
treatment of avian reovirions, these transcripts could be the trigger for IFN induction. 
On the other hand, ribavirin has been shown to block transcription elongation, but not 
the initiation of RNA synthesis (Rankin et al., 1989), so abortive reoviral transcripts 
generated in ribavirin-treated cells might act as IFN inducers. 
 That lysosomotropic agents prevent IFN induction when added to ARV-infected 




































































intraendosomal virus uncoating is necessary to trigger IFN expression and that the 
expression of IFN is induced at a post-attachment step. Our findings that IFN induction 
requires virus uncoating but not viral gene expression suggests that the viral PAMPs 
detected by the cellular PRRs should be ARV products generated or exposed upon 
intraendosomal uncoating, and not by intact viral particles. These products might be 
core proteins or viral nucleic acids, like the adenine-rich oligonucleotides or the genome 
segments present in ARV particles. Since reovirus cores must cross the endosomal 
membrane to reach the cytoplasm for expressing the viral genes, cellular PRRs for the 
detection of ARV infection could be endosomal-associated PRRs, such as toll-like 
receptors, or cytoplasmic PRRs, such as RIG-helicases. Additional studies are needed to 
identify both the viral trigger and the cellular sensor that are responsible for IFN 
induction in ARV-infected avian cells. 
 Data presented in this report indicates that PKR expression is induced in ARV-
infected CEF cells, but not in VSV- or VV-infected cells, and that the expression of this 
kinase is indirectly induced by the IFN secreted by ARV-infected cells. On the other 
hand, in a previous report we have presented evidences that the ARV protein sigmaA 
exerts an anti-IFN function by preventing PKR activation (Gonzalez-Lopez et al., 
2003). Although the role that PKR plays on ARV replication is the subject of another 
study (manuscript in preparation), we can speculate that PKR expression might benefit 
ARV replication by promoting the selective inhibition of cellular protein synthesis 
observed in ARV-infected CEF (Martinez-Costas et al., 2000; Labrada et al., 2002). 
Thus, as has been reported for mammalian reovirus protein sigma3 (Schmechel, et al., 
1997), localization of sigmaA in and around perinuclear viral factories would prevent 
PKR activation and allow the translation of viral mRNAs, while PKR would be 




































































Alternatively, the sigmaA protein expressed in ARV-infected cells might partially 
inhibit PKR activation, leading to intracellular levels of phosphorylated eIF-2 that 
would block the translation of cellular mRNAs, but not of their viral counterparts. A 
pro-viral effect of PKR expression has similarly been reported for the replication of 
mammalian reoviruses (Smith et al., 2005). 
  







































































MATERIALS AND METHODS 
Cells and viruses  
Primary cultures of CEF cells were prepared from 9- to 10-day-old embryos from 
specific pathogenic free chickens, and grown as monolayers in medium 199 
supplemented with 10% tryptose phosphate broth and 5% calf serum. Chicken 
fibroblast DF-1 cells and baby hamster kidney BHK-21 cells were grown as monolayers 
in Dulbecco’s Modified Eagle’s medium (D-MEM, Invitrogen). Vaccinia virus (VV; 
Western Reserve strain) and Vesicular Stomatitis Virus (VSV; Indiana serotype) were 
grown on BHK-21 cell monolayers. Avian reovirus (ARV) strain S1133 was grown on 
semiconfluent monolayers of CEF cells, and purified by CsCl-gradient centrifugation as 
previously described (Grande and Benavente, 2000), except that Freon was replaced by 
Vertrel-XF (Mendez et al., 2000). 
For ultraviolet inactivation, purified ARV virions kept on ice were exposed to a 254 nm 
UV light for 15 min, as described by Tyler et al. (1995). UV-inactivated virus was 
devoid of infectious virus particles as determined by plaque assay. 
Antibodies, plasmids and reagents 
Anti-actin antibody (rabbit polyclonal, sc-1616R) was purchased from Santa Cruz 
Biotechnology and HRP-conjugated goat anti-rabbit IgG from Sigma. Rabbit polyclonal 
anti-muNS protein was raised in our laboratory (Tourís-Otero et al., 2004). Rabbit 
polyclonal anti-chicken PKR antibody was generated by BioSynthesis, using as 
immunogen a KLH-conjugated synthetic peptide comprising amino acids 527-550 of 
chicken PKR. Rabbit antibodies against chicken IFNs  and  were a kind gift from Dr. 




































































The reporter plasmid that contains the luciferase gen under the control of the chicken 
Mx promoter (pGL3-P-chMx-Luc) was a gift from Dr. Nicolas Ruggli (Liniger et al., 
2012). Ammonium chloride, chloroquine, ribavirin and brefeldin A were purchased 
from Sigma, the pancaspase inhibitor Q-VD-OPh was from Calbiochem, lipofectamine 
from Invitrogen and the recombinant chicken IFN alpha from AbD-Serotec (#PAP004).  
Western blotting 
Cells were washed twice with PBS, lysed in Laemmli sample buffer (Laemmli, 1970) 
and boiled for 5 min. The resulting extracts were then subjected to SDS-PAGE 
electrophoresis, and the gel proteins transferred to PVDF membranes (Immobilon-P, 
Millipore) for 1 h at 100 V using a trans-blot electrophoretic transfer unit (Bio-Rad). 
Membranes were blocked for 1 h with PBS containing 0.05% Tween-20 and 4% non-fat 
dry milk, and incubated for 2 h with the primary antibodies diluted in blocking solution. 
After several washes, membranes were incubated for 45 min with HRP-conjugated goat 
anti-rabbit IgG and visualized by chemiluminescence (Immobilon Western 
Chemiluminescent HRP Substrate, Millipore). 
Preparation of virus-free supernatants and Mx-promoter activation assays 
The virus was removed from the supernatants by perchloric acid (PCA) precipitation 
(Sekellick and Marcus, 1986). Briefly, foetal bovine serum in the culture medium was 
raised to 6% before adding 0.15 volumes of cold PCA. Samples were incubated for 24 h 
in a cold room and the precipitate removed by centrifugation at 2000 rpm 10 min. PCA 
in the supernatant was neutralized with KOH, and the pH adjusted to 6.8. The 
precipitate that forms after neutralization was removed by centrifugation, and the IFN-
containing supernatant was filter-sterilized through a 0.22-M Millex filter (Millipore) 




































































centrifugated at 4ºC for 5 min at 2000 rpm to remove cellular debris, and the resulting 
supernatants were incubated at 65ºC for 30 min to inactivate the virus (Liniger et al., 
2012). 
To determine the activation of the chicken Mx promoter, monolayers of DF-1 cells were 
transfected with the pGL3-P-chMx-luc plasmid and incubated 24 h later with either 50 
l of virus-free supernatants or 100 U/ml of IFN for 24 h. The cells were then harvested 
and lysed in CCLR buffer (Promega). The luciferase activity of the extracts was 
determined with a Luminoskan Ascent luminometer. 
Quantitative real-time PCR of chIFN- mRNA levels in ARV-infected CEF cells. 
CEF cell monolayers were infected with 2 PFU/cell of ARV S1133, and at 0, 3 and 6 
hpi cell samples were collected and their RNA was extracted using Trizol (Life 
Technologies). The RNA samples were treated with DNase RQ I (Promega) for 35 min 
at 37ºC and the enzyme was subsequently inactivated by incubation at at 65ºC for 10 
min in the presence of DNase Stop Solution (Promega). Total RNA was reverse 
transcribed into cDNA using the iScript
TM
 cDNA Synthesis kit (Bio-Rad) according to 
the manufacturer’s instructions and the following incubation times: 25ºC for 5 min, 42 
ºC for 40 min and 85ºC for 5 min. Then the exonuclease activity of the reverse 
transcriptase was heat-inactivated at 95ºC for 5 min. The cDNA was diluted 10 times in 
water, aliquoted and stored at -80ºC. For quantitative PCR amplification the following 
primers were used.  
qPCR reactions of 10 µl contained 5 µl of IQ SYBR Green Super Mix (Bio-Rad), 2.5 µl 
of cDNA and 300 nM of each primer. For the detection of chicken IFN-β mRNA 
(NM_001024836.1), the forward primer was 5’CAACACCTCTTCAACATGCTTAG 
3’ and the reverse primer was 5’TGCTCAAGGTGATGGATGTAAT 3’. These primers 




































































a Tm of 63.4ºC). An initial denaturalization step of 3 min at 95ºC was followed by 40 
cycles (10 s at 95ºC, 30 s at 63.4ºC and 10 s at 72ºC) using a C1000 Touch 
thermocycler with a CFX96 optical module (Bio-Rad). An end-point single 
fluorescence was measured after each extension step. After the amplification we carried 
out an analysis of the dissociation curve from 65 to 95ºC by raising the temperature 
0.5ºC every 5 s, to verify the specificity of the obtained products. The results were 
analysed and processed with the CFX Manager software (Bio-Rad). The relative 
amount of the mRNA was normalized to the internal β-actin control, and chicken β-
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Figure 1. IFN induction by virus-infected CEF cells. (A) CEF monolayers were 
mock-infected (U) or infected with 2 PFU/cell of the viruses indicated on top. At 18 hpi 
the cells were lysed and the resulting extracts were analyzed by Western blot with anti-
chPKR (top panel) and anti-actin (bottom panel) antibodies. (B) Virus-free supernatants 
from the same cells shown in Fig. 1A were added to the culture medium of CEF cell 
monolayers and 24 h later the cells were lysed and the intracellular PKR and actin levels 
were compared by Western blotting. A Western blot analysis of extracts from 
uninfected CEF cells that were incubated with 1000 U/ml of chIFN for 24 h is shown in 
lanes 5 of Figs. 1A and 1B. (C) Virus-free supernatants from the same cells shown in 
Fig. 1A were added to the culture medium of DF1 cells that had been transfected with 
the pGL3-P-chMx-luc plasmid. These cells, as well as IFN-primed uninfected cells, 
were lysed 24 h later and the luciferase activity of the extracts was determined with a 
luminometer. The induction of the Mx promoter-dependent firefly luciferase was 
expressed as fold induction compared to that of unstimulated cells. The data are 
representative of three independent experiments. The error bars indicate the standard 
deviation of three measurements for each experiment. 
 
Figure 2. ARV-infected CEF cells express type- and type- IFNs. (A) The cultured 
medium of CEF cells infected with 2 PFU/cell of ARV S1133 was supplemented at the 
onset of the infection with antibodies against type-IFN (lane 3), type-IFN (lane 4), 
each at the concentration of 2%, or with the two antibodies (lane 5) and incubated for 18 
h. These cells, as well as mock-infected nontreated cells (lane 1) and mock-infected 
cells primed with IFN for 24 h (lane 6), were lysed and the extracts analyzed by 




































































(B) Mock-infected CEF cells, either untreated (lanes 1-3) or primed with IFN for 24 h 
(lane 7), as well as CEF cells infected with 2 PFU/cell of ARV, were incubated from the 
onset of the infection with the concentrations of brefeldin A (BFA) indicated on top. 
The cells were lysed at 18 hpi and the resulting extracts analyzed by Western blotting 
with antibodies against the proteins indicated on the right. The sample in lane 7 was run 
on the same gel, but two internal lanes were removed. 
 
Figure 3. IFN is induced at early infection times in ARV-infected CEF. CEF cell 
monolayers were infected with 2 PFU/cell of ARV for the hours indicated. (A) The cells 
were harvested for RNA isolation, and virus-induced expression of chIFN-was 
determined by real-time PCR. The data are representative of three independent 
experiments, with the error bars indicating the standard deviations of the mean. (B) The 
infected cells, as well as IFN-primed noninfected cells (lane 7), were lysed and the 
extracts subjected to Western blot analysis with the antibodies indicated on the right. 
(C) The capacity to activate the Mx promoter of virus-free supernatants from the cells 
shown in Fig. 3A was determined as for Fig. 1C. The data are representative of three 
independent experiments, with the error bars indicating the standard deviations of the 
mean.  
 
Figure 4. Induction of IFN expression requires ARV uncoating. (A) CEF cells 
infected with 2 PFU/cell of ARV (lanes 2-6) were treated with 100 M chloroquine 
(lanes 3 and 4)  or with 10 mM ammonium chloride (lanes 5 and 6), from the onset of 
the infection (lanes 3 and 5) or from 3 hpi (lanes 4 and 6). At 18 hpi these cells, as well 
as mock-infected nontreated cells (lane 1) and mock-infected cells primed with IFN for 




































































against the proteins indicated at the right of the figure. (B) The capacity to activate the 
Mx promoter of virus-free supernatants from the cells shown in Fig. 4A was determined 
as for Fig. 1C. The data are representative of three independent experiments, with the 
error bars indicating the standard deviations of the mean. 
 
Fig. 5. ARV gene expression is not required for IFN induction. (A) Mock-infected 
CEF (lanes 1 and 2) and ARV-infected CEF (lanes 3 and 4) were incubated from the 
onset of the infection with 100 M ribavirin (lanes 2 and 4). At 18 hpi these cells, as 
well as IFN-primed uninfected cells (lane 5) were lysed and the extracts subjected to 
Western blot analysis with antibodies against the proteins indicated on the right. (B) 
The capacity to activate the Mx promoter of virus-free supernatants from the cells 
shown in Fig. 5A was determined as for Fig. 1C. The data are representative of three 
independent experiments, with the error bars indicating the standard deviations of the 
mean. (C) Monolayers of CEF were mock infected (lane 1) or infected with purified 
ARV virions that had been inactivated (lane 3) or not (lane 2) by UV light treatment. At 
18 hpi the cells were lysed and the extracts analyzed by Western blotting with 
antibodies against the proteins indicated on the right. (D) The capacity to activate the 
Mx promoter of virus-free supernatants from the cells shown in Fig. 5C was determined 
as for Fig. 1C. The data are representative of three independent experiments, with the 
error bars indicating the standard deviations of the mean. 
 
Fig. 6. Effect of Q-VD-OPh on caspase activity and IFN induction. (A) CEF 
monolayers were mock-infected (U) or infected with 2 PFU/cell of ARV in the absence 
(lanes -) or presence (lanes +) of 10 μM Q-VD-OPh. At 18 hpi caspase activity was 




































































instructions, and the results were expressed as arbitrary RLU units. Each value is the 
mean of three independent experiments. (B) A replica of the cells shown in Fig. 6A 
were lysed at 18 hpi and the cell extracts were subjected to Western blot analysis with 
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